This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2025 Nov 7.

doi: 10.1038/s41587-025-02941-0. Online ahead of print.

Publisher Correction: Deep-learning-based virtual screening of antibacterial compounds

Gabriele Scalia^#¹, Steven T Rutherford^#², Ziqing Lu³, Kerry R Buchholz², Nicholas Skelton⁴, Kangway Chuang³, Nathaniel Diamant³, Jan-Christian Hütter³, Jerome-Maxim Luescher³, Anh Miu², Jeff Blaney⁴, Leo Gendelev⁴, Elizabeth Skippington⁵, Greg Zynda⁶, Nia Dickson⁶, Michał Koziarski⁷, Yoshua Bengio⁷, Aviv Regev⁸, Man-Wah Tan², Tommaso Biancalani⁹

Affiliations

Affiliations

¹ gRED Computational Sciences, Genentech Research and Early Development, San Francisco, CA, USA. scalia.gabriele@gene.com.
² Genentech Infectious Diseases, San Francisco, CA, USA.
³ gRED Computational Sciences, Genentech Research and Early Development, San Francisco, CA, USA.
⁴ Genentech Small Molecules Drug Discovery, San Francisco, CA, USA.
⁵ Genentech OMNI Bioinformatics, San Francisco, CA, USA.
⁶ NVIDIA Corporation, Santa Clara, CA, USA.
⁷ MILA-Québec AI Institute, Université de Montréal, Montreal, Quebec, Canada.
⁸ Genentech Research and Early Development, San Francisco, CA, USA.
⁹ gRED Computational Sciences, Genentech Research and Early Development, San Francisco, CA, USA. biancalani.tommaso@gene.com.

^# Contributed equally.

PMID: 41203993
DOI: 10.1038/s41587-025-02941-0

Published Erratum

Publisher Correction: Deep-learning-based virtual screening of antibacterial compounds

Gabriele Scalia et al. Nat Biotechnol. 2025.

. 2025 Nov 7.

doi: 10.1038/s41587-025-02941-0. Online ahead of print.

Authors

Gabriele Scalia^#¹, Steven T Rutherford^#², Ziqing Lu³, Kerry R Buchholz², Nicholas Skelton⁴, Kangway Chuang³, Nathaniel Diamant³, Jan-Christian Hütter³, Jerome-Maxim Luescher³, Anh Miu², Jeff Blaney⁴, Leo Gendelev⁴, Elizabeth Skippington⁵, Greg Zynda⁶, Nia Dickson⁶, Michał Koziarski⁷, Yoshua Bengio⁷, Aviv Regev⁸, Man-Wah Tan², Tommaso Biancalani⁹

Affiliations

¹ gRED Computational Sciences, Genentech Research and Early Development, San Francisco, CA, USA. scalia.gabriele@gene.com.
² Genentech Infectious Diseases, San Francisco, CA, USA.
³ gRED Computational Sciences, Genentech Research and Early Development, San Francisco, CA, USA.
⁴ Genentech Small Molecules Drug Discovery, San Francisco, CA, USA.
⁵ Genentech OMNI Bioinformatics, San Francisco, CA, USA.
⁶ NVIDIA Corporation, Santa Clara, CA, USA.
⁷ MILA-Québec AI Institute, Université de Montréal, Montreal, Quebec, Canada.
⁸ Genentech Research and Early Development, San Francisco, CA, USA.
⁹ gRED Computational Sciences, Genentech Research and Early Development, San Francisco, CA, USA. biancalani.tommaso@gene.com.

^# Contributed equally.

PMID: 41203993
DOI: 10.1038/s41587-025-02941-0

No abstract available

PubMed Disclaimer

Erratum for

Deep-learning-based virtual screening of antibacterial compounds.
Scalia G, Rutherford ST, Lu Z, Buchholz KR, Skelton N, Chuang K, Diamant N, Hütter JC, Luescher JM, Miu A, Blaney J, Gendelev L, Skippington E, Zynda G, Dickson N, Koziarski M, Bengio Y, Regev A, Tan MW, Biancalani T. Scalia G, et al. Nat Biotechnol. 2025 Oct 24. doi: 10.1038/s41587-025-02814-6. Online ahead of print. Nat Biotechnol. 2025. PMID: 41136774

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group